Claude agent reportedly picks a gene therapy and performs mouse brain surgery without a human in the loop

A startup reportedly let a Claude agent choose a gene therapy, plot coordinates and run a needle on a live mouse's brain. The agent reportedly ran on Claude Sonnet 5 without a human in the loop. Opus reportedly refused the task, while Sonnet agreed to it.